139 related articles for article (PubMed ID: 16126882)
1. CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact.
Kontogianni K; Nicholson AG; Butcher D; Sheppard MN
J Clin Pathol; 2005 Sep; 58(9):978-80. PubMed ID: 16126882
[TBL] [Abstract][Full Text] [Related]
2. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
[TBL] [Abstract][Full Text] [Related]
3. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
4. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
Zheng G; Ettinger DS; Maleki Z
Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
[TBL] [Abstract][Full Text] [Related]
5. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
Liu J; Farhood A
Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
[TBL] [Abstract][Full Text] [Related]
7. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy.
Farinola MA; Weir EG; Ali SZ
Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric detection of small cell lung cancer cells with aberrant CD45 expression in micrometastatic bone marrow.
Danbara M; Yoshida M; Kanoh Y; Jiang SX; Masuda N; Akahoshi T; Higashihara M
Jpn J Clin Oncol; 2009 Nov; 39(11):771-5. PubMed ID: 19674995
[TBL] [Abstract][Full Text] [Related]
9. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
11. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
[TBL] [Abstract][Full Text] [Related]
12. CD56 staining in Merkel cell carcinoma and natural killer-cell lymphoma: magic bullet, diagnostic pitfall, or both?
McNiff JM; Cowper SE; Lazova R; Subtil A; Glusac EJ
J Cutan Pathol; 2005 Sep; 32(8):541-5. PubMed ID: 16115052
[TBL] [Abstract][Full Text] [Related]
13. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
[TBL] [Abstract][Full Text] [Related]
14. [Significance of MOC-31 and CD56 detection in human lung carcinoma tissues].
Huang YG; Xu YY; Zheng ZH
Ai Zheng; 2002 Nov; 21(11):1235-7. PubMed ID: 12526223
[TBL] [Abstract][Full Text] [Related]
15. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
16. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
Chang YL; Lee YC; Liao WY; Wu CT
Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
[TBL] [Abstract][Full Text] [Related]
17. Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components.
Wagner PL; Kitabayashi N; Chen YT; Saqi A
Am J Clin Pathol; 2009 Mar; 131(3):376-82. PubMed ID: 19228643
[TBL] [Abstract][Full Text] [Related]
18. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
Uke M; Rekhi B; Ajit D; Jambhekar NA
Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
[TBL] [Abstract][Full Text] [Related]
19. Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Kishi K; Uei Y; Shimosato Y
Acta Cytol; 1991; 35(5):485-90. PubMed ID: 1656682
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of tumor markers in lung biopsies and in bronchial lavage].
Vogel J; Loos U; Oehr P
Pneumologie; 1990 Feb; 44 Suppl 1():465-6. PubMed ID: 2164199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
